Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green for Pelvic Nerve Visualization in Cervical Cancer Surgery
NCT05087264Phase 1Unknown
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of indocyanine green in Cervical Cancer (CC) (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Main indicators of bladder function recovery at 7 days. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT05087264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087264.